- Report
- October 2024
- 185 Pages
Global
From €3403EUR$3,545USD£2,840GBP
€3781EUR$3,939USD£3,155GBP
- Report
- March 2025
- 50 Pages
Global
From €2544EUR$2,650USD£2,123GBP
Brotizolam is a benzodiazepine drug used to treat mental disorders such as anxiety, panic attacks, and insomnia. It is a short-acting drug, meaning it has a rapid onset of action and a short duration of effect. It is commonly prescribed for short-term relief of symptoms, and is not recommended for long-term use due to its potential for dependence and abuse. Brotizolam is available in tablet form and is usually taken orally.
Brotizolam is a widely used drug in the treatment of mental disorders, and is often prescribed in combination with other medications. It is generally considered to be a safe and effective treatment for anxiety and insomnia, although it can cause side effects such as drowsiness, dizziness, and confusion.
The market for Brotizolam is highly competitive, with many companies offering the drug in various forms. Some of the major companies in the market include Pfizer, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more